slide 1
at 1
Reddy 1
Profits 1
India's 1
Dr 1
slide 1
at 1
Reddy 1
Profits 1
India's 1
Dr 1
at 2
Profits 2
Dr 2
slide 1
sales 1
rose 1
research 1
flagged. 1
fell 1
drugmaker 1
costs 1
as 1
and 1
Reddy's 1
Reddy 1
Indian 1
India's 1
93% 1
at 2
Profits 2
Dr 2
slide 1
sales 1
rose 1
research 1
flagged. 1
fell 1
drugmaker 1
costs 1
as 1
and 1
Reddy's 1
Reddy 1
Indian 1
India's 1
93% 1
the 9
in 7
of 6
and 5
a 5
to 4
on 4
Dr 4
its 3
for 3
version 2
sales 2
rupees 2
profits 2
new 2
key 2
it 2
is 2
has 2
generic 2
from 2
firm 2
fell 2
at 2
are 2
The 2
Reddy's 2
Profits 2
Indian 2
December 2
£486,000) 1
won 1
with 1
whose 1
which 1
were 1
well-known 1
was 1
versions 1
three 1
that 1
spending 1
slide 1
short 1
shares 1
selling 1
sales. 1
said 1
rupees. 1
run 1
rose 1
rising 1
rights 1
research 1
reputation 1
representing 1
recent 1
products. 1
products 1
product 1
producing 1
popular 1
pharmaceutical 1
out 1
other 1
opportunity 1
number 1
near 1
most 1
months 1
marketing 1
manufacturers. 1
maker, 1
lost 1
listed 1
launches. 1
intensified 1
hypertension 1
had 1
generics 1
future, 1
flagged. 1
famous 1
fall 1
exclusive 1
due 1
drugs 1
drugmaker 1
drug 1
development 1
decrease 1
court 1
costs 1
continuing 1
competition 1
company 1
cause 1
case 1
built 1
big-name 1
banning 1
as 1
apace, 1
anti-depressant 1
annoucement 1
an 1
also 1
alongside 1
York, 1
US. 1
Research 1
Reddy, 1
Reddy 1
R&D 1
Prozac 1
Pfizer's 1
Patents 1
Norvasc 1
New 1
March 1
Lilly. 1
It 1
India's 1
Eli 1
But 1
93% 1
8% 1
705m 1
40m 1
4.7bn 1
37% 1
2004, 1
2000 1
- 1
($915,000; 1
the 9
in 7
of 6
and 5
a 5
to 4
on 4
Dr 4
its 3
for 3
version 2
sales 2
rupees 2
profits 2
new 2
key 2
it 2
is 2
has 2
generic 2
from 2
firm 2
fell 2
at 2
are 2
The 2
Reddy's 2
Profits 2
Indian 2
December 2
£486,000) 1
won 1
with 1
whose 1
which 1
were 1
well-known 1
was 1
versions 1
three 1
that 1
spending 1
slide 1
short 1
shares 1
selling 1
sales. 1
said 1
rupees. 1
run 1
rose 1
rising 1
rights 1
research 1
reputation 1
representing 1
recent 1
products. 1
products 1
product 1
producing 1
popular 1
pharmaceutical 1
out 1
other 1
opportunity 1
number 1
near 1
most 1
months 1
marketing 1
manufacturers. 1
maker, 1
lost 1
listed 1
launches. 1
intensified 1
hypertension 1
had 1
generics 1
future, 1
flagged. 1
famous 1
fall 1
exclusive 1
due 1
drugs 1
drugmaker 1
drug 1
development 1
decrease 1
court 1
costs 1
continuing 1
competition 1
company 1
cause 1
case 1
built 1
big-name 1
banning 1
as 1
apace, 1
anti-depressant 1
annoucement 1
an 1
also 1
alongside 1
York, 1
US. 1
Research 1
Reddy, 1
Reddy 1
R&D 1
Prozac 1
Pfizer's 1
Patents 1
Norvasc 1
New 1
March 1
Lilly. 1
It 1
India's 1
Eli 1
But 1
93% 1
8% 1
705m 1
40m 1
4.7bn 1
37% 1
2004, 1
2000 1
- 1
($915,000; 1
the 15
in 10
of 9
and 7
to 6
Dr 6
a 5
on 4
for 4
Reddy's 4
rupees 3
its 3
from 3
fell 3
at 3
are 3
Indian 3
were 2
version 2
sales 2
rupees. 2
profits 2
new 2
key 2
it 2
is 2
has 2
generics 2
generic 2
firm 2
face 2
competition 2
also 2
The 2
Sales 2
Profits 2
December 2
£486,000) 1
year 1
won 1
with 1
whose 1
which 1
well-known 1
was 1
versions 1
too 1
three 1
they 1
that 1
than 1
strong 1
strength 1
staple 1
spending 1
slide 1
short 1
shares 1
selling 1
sales. 1
sale 1
said 1
run 1
rose 1
rising 1
rights 1
research 1
reputation 1
representing 1
recent 1
products. 1
products 1
product 1
producing 1
previous 1
pressures. 1
popular 1
poorly. 1
pharmaceutical 1
performed 1
out 1
other 1
opportunity 1
number 1
near 1
most 1
more 1
months 1
marketing 1
manufacturers. 1
maker, 1
lost 1
listed 1
launches. 1
intensified 1
ingredients 1
hypertension 1
home, 1
heavy 1
had 1
gathering 1
future, 1
flagged. 1
firm's 1
famous 1
fall 1
exclusive 1
due 1
drugs, 1
drugs 1
drugmaker 1
drug 1
down 1
development 1
decrease 1
court 1
costs 1
continuing 1
competitors 1
competitive 1
company 1
cause 1
case 1
business, 1
business 1
built 1
both 1
big-name 1
banning 1
as 1
apace, 1
anti-depressant 1
annoucement 1
an 1
although 1
alongside 1
York, 1
US. 1
US 1
Research 1
Reddy, 1
Reddy 1
R&D 1
Prozac 1
Pfizer's 1
Patents 1
Norvasc 1
New 1
March 1
Lilly. 1
It 1
India's 1
Europe. 1
Eli 1
But 1
Another 1
966m 1
93% 1
8.6% 1
8% 1
705m 1
40m 1
4.7bn 1
37% 1
25% 1
2004, 1
2000 1
1.4bn 1
- 1
($915,000; 1
